FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

714187005: Product containing trastuzumab in parenteral dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2016. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3298422013 Parenteral form trastuzumab en Synonym Inactive Only initial character case insensitive SNOMED CT core module
3298674019 Parenteral form trastuzumab (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
3488548019 Product containing trastuzumab in parenteral dosage form (medicinal product form) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
3497578010 Trastuzumab in parenteral dosage form en Synonym Inactive Entire term case insensitive SNOMED CT core module
3497579019 Product containing trastuzumab in parenteral dosage form en Synonym Inactive Entire term case insensitive SNOMED CT core module
3712236014 Product containing trastuzumab in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3712237017 Trastuzumab-containing product in parenteral dose form en Synonym Active Entire term case insensitive SNOMED CT core module

14 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing trastuzumab in parenteral dose form (medicinal product form) Is a Product containing trastuzumab true Inferred relationship Existential restriction modifier
Product containing trastuzumab in parenteral dose form (medicinal product form) Is a Product manufactured as parenteral dose form true Inferred relationship Existential restriction modifier
Product containing trastuzumab in parenteral dose form (medicinal product form) Has active ingredient Trastuzumab true Inferred relationship Existential restriction modifier 1
Product containing trastuzumab in parenteral dose form (medicinal product form) Has manufactured dose form Parenteral dose form true Inferred relationship Existential restriction modifier
Product containing trastuzumab in parenteral dose form (medicinal product form) Plays role Antineoplastic therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection Is a False Product containing trastuzumab in parenteral dose form (medicinal product form) Inferred relationship Existential restriction modifier
Product containing precisely trastuzumab 440 milligram/1 vial powder for conventional release solution for injection (clinical drug) Is a False Product containing trastuzumab in parenteral dose form (medicinal product form) Inferred relationship Existential restriction modifier
Product containing only trastuzumab in parenteral dose form (medicinal product form) Is a True Product containing trastuzumab in parenteral dose form (medicinal product form) Inferred relationship Existential restriction modifier
Product containing trastuzumab deruxtecan in parenteral dose form (medicinal product form) Is a False Product containing trastuzumab in parenteral dose form (medicinal product form) Inferred relationship Existential restriction modifier
Product containing trastuzumab emtansine in parenteral dose form (medicinal product form) Is a False Product containing trastuzumab in parenteral dose form (medicinal product form) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start